Scientific Publications
SphingoTec's biomarker discovery is based on the highest standard of evidence, with over 100 publications, over 100 clinical studies, and more than 100.000 patients enrolled. Browse our scientific publications to learn more about how our biomarkers can impact patient care. You can use filters to narrow your search results by Year, Biomarker and Indications.
Filter
Results
2023
bio-ADM
penKid
Other
2023
penKid
Acute Kidney Injury
Other
2023
penKid
Acute Kidney Injury
Other
2023
bio-ADM
penKid
Major Surgery
Other
2022
penKid
pro-ENK
Acute Kidney Injury
Other
2022
bio-ADM
Sepsis
Other
2022
DPP3
Cardiovascular Disease
Sepsis
Other
2022
bio-ADM
penKid
Sepsis
Other
2022
DPP3
Cardiogenic Shock
Sepsis
Other
2022
penKid
Acute Kidney Injury
Other
2022
bio-ADM
Sepsis
Other
2022
penKid
Acute Kidney Injury
Sepsis
Other
2022
pro-NT
Other
2021
bio-ADM
DPP3
Other
2020
penKid
Other
2019
pro-NT
Other
2019
pro-TA
pro-ENK
hGH
Other
2018
penKid
Other
2018
pro-NT
Cardiovascular Disease
Other
2017
penKid
Other
2017
bio-ADM
Other
2016
pro-NT
Other
2016
pro-NT
Other
2015
pro-TA
pro-ENK
pro-NT
Other
2012
pro-NT
Cardiovascular Disease
Other